-
Je něco špatně v tomto záznamu ?
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
L. Naehrlich, A. Orenti, F. Dunlevy, I. Kasmi, S. Harutyunyan, A. Pfleger, S. Keegan, G. Daneau, G. Petrova, D. Tješić-Drinković, P. Yiallouros, A. Bilkova, HV. Olesen, PR. Burgel, T. Parulava, F. Diamantea, A. Párniczky, EF. McKone, M....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, pozorovací studie
- MeSH
- COVID-19 diagnóza epidemiologie terapie MeSH
- cystická fibróza komplikace mortalita terapie MeSH
- dítě MeSH
- dospělí MeSH
- hospitalizace MeSH
- incidence MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- novorozenec MeSH
- péče o pacienty v kritickém stavu MeSH
- předškolní dítě MeSH
- registrace MeSH
- retrospektivní studie MeSH
- transplantace plic MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: Viral infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of people with CF (pwCF). METHODS: We used the 38-country European Cystic Fibrosis Society Patient Registry (ECFSPR) to collect case data about pwCF and SARS-CoV-2 infection. RESULTS: Up to 30 June 2020, 16 countries reported 130 SARS-CoV-2 cases in people with CF, yielding an incidence of 2.70/1000 pwCF. Incidence was higher in lung-transplanted patients (n=23) versus non-transplanted patients (n=107) (8.43 versus 2.36 cases/1000). Incidence was higher in pwCF versus the age-matched general population in the age groups <15, 15-24, and 25-49 years (p<0.001), with similar trends for pwCF with and without lung transplant. Compared to the general population, pwCF (regardless of transplantation status) had significantly higher rates of admission to hospital for all age groups with available data, and higher rates of intensive care, although not statistically significant. Most pwCF recovered (96.2%), however 5 died, of whom 3 were lung transplant recipients. The case fatality rate for pwCF (3.85%, 95% CI: 1.26-8.75) was non-significantly lower than that of the general population (7.46%; p=0.133). CONCLUSIONS: SARS-CoV-2 infection can result in severe illness and death for pwCF, even for younger patients and especially for lung transplant recipients. PwCF should continue to shield from infection and should be prioritized for vaccination.
1 Tsitsishvili Children's Clinic CF Centre Tblisi Georgia
Alexandrovska University Hospital Pediatric Clinic Sofia Bulgaria
Centre for Cystic Fibrosis Hospital de Santa Maria Lisbon Portugal
Centre for Cystic Fibrosis University Children's Hospital Skopje North Macedonia
CF Center University of Cologne Faculty of Medicine Cologne Germany
Cystic Fibrosis Centre University Hospital of Bratislava Bratislava Slovakia
Cystic Fibrosis Registry of the Czech Republic Prague Czech Republic
Cystic Fibrosis Registry of Turkey Ankara Turkey
Cystic Fibrosis Trust London UK
Department of Pulmonology Hôpital Robert Schuman Luxembourg Luxembourg
Dutch Cystic Fibrosis Foundation Baarn The Netherlands
Dziekanow Paediatric Hospital Cystic Fibrosis Centre Institute of Mother and Child Warsaw Poland
European Cystic Fibrosis Society Karup Denmark
Heim Pál National Pediatric Institute Budapest Hungary
Institute for Translational Medicine University of Pécs Medical School Pécs Hungary
Institute of Hereditary Pathology Ukrainian National Academy of Medical Sciences Lviv Ukraine
Laboratory of genetic epidemiology Research Centre for Medical Genetics Moscow Russian Federation
Medical School University of Cyprus Nicosia Cyprus
Mother Thereza Hospital Center Department of Paediatrics Tirana Albania
Norwegian Resource Centre for Cystic Fibrosis Oslo University Hospital Oslo Norway
Paediatric Pulmonology University Children`s Hospital Zurich Zurich Switzerland
Pulmonary Institute Schneider Children's Medical Center of Israel Petah Tikva Israel
Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel
Sciensano Epidemiology and public health Health services research Brussels Belgium
Sismanoglio General Hospital of Attica Adult Cystic Fibrosis Unit Athens Greece
St Vincent's University Hospital and University College Dublin School of Medicine Dublin Ireland
Stockholm CF centre Karolinska University Hospital Karolinska Institutet Stockholm Sweden
University Hospital Centre Zagreb Cystic Fibrosis Centre Paediatrics and Adults Zagreb Croatia
Yerevan University CF Centre Muratsan Hospital Yerevan Armenia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025462
- 003
- CZ-PrNML
- 005
- 20211026133801.0
- 007
- ta
- 008
- 211013s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jcf.2021.03.017 $2 doi
- 035 __
- $a (PubMed)34016559
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Naehrlich, Lutz $u Universities of Giessen and Marburg Lung Center, German Center of Lung Research, Justus-Liebig-University Giessen, Giessen, Germany
- 245 10
- $a Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 / $c L. Naehrlich, A. Orenti, F. Dunlevy, I. Kasmi, S. Harutyunyan, A. Pfleger, S. Keegan, G. Daneau, G. Petrova, D. Tješić-Drinković, P. Yiallouros, A. Bilkova, HV. Olesen, PR. Burgel, T. Parulava, F. Diamantea, A. Párniczky, EF. McKone, M. Mei-Zahav, M. Salvatore, C. Colombo, E. Aleksejeva, K. Malakauskas, M. Schlesser, S. Fustik, O. Turcu, D. Zomer-van Ommen, AS. Wathne, Ł. Woźniacki, L. Pereira, L. Pop, N. Kashirskaya, M. Rodić, H. Kayserova, U. Krivecs, P. Mondejar-Lopez, I. de Monestrol, D. Dogru, H. Makukh, R. Cosgriff, S. van Koningsbruggen-Rietschel, A. Jung, European Cystic Fibrosis COVID project group
- 520 9_
- $a BACKGROUND: Viral infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of people with CF (pwCF). METHODS: We used the 38-country European Cystic Fibrosis Society Patient Registry (ECFSPR) to collect case data about pwCF and SARS-CoV-2 infection. RESULTS: Up to 30 June 2020, 16 countries reported 130 SARS-CoV-2 cases in people with CF, yielding an incidence of 2.70/1000 pwCF. Incidence was higher in lung-transplanted patients (n=23) versus non-transplanted patients (n=107) (8.43 versus 2.36 cases/1000). Incidence was higher in pwCF versus the age-matched general population in the age groups <15, 15-24, and 25-49 years (p<0.001), with similar trends for pwCF with and without lung transplant. Compared to the general population, pwCF (regardless of transplantation status) had significantly higher rates of admission to hospital for all age groups with available data, and higher rates of intensive care, although not statistically significant. Most pwCF recovered (96.2%), however 5 died, of whom 3 were lung transplant recipients. The case fatality rate for pwCF (3.85%, 95% CI: 1.26-8.75) was non-significantly lower than that of the general population (7.46%; p=0.133). CONCLUSIONS: SARS-CoV-2 infection can result in severe illness and death for pwCF, even for younger patients and especially for lung transplant recipients. PwCF should continue to shield from infection and should be prioritized for vaccination.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a COVID-19 $x diagnóza $x epidemiologie $x terapie $7 D000086382
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a péče o pacienty v kritickém stavu $7 D003422
- 650 _2
- $a cystická fibróza $x komplikace $x mortalita $x terapie $7 D003550
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a transplantace plic $7 D016040
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Orenti, Annalisa $u Department of Clinical Sciences and Community Health, Laboratory of Medical Statistics, Epidemiology and Biometry G. A. Maccacaro, University of Milan, Milan, Italy
- 700 1_
- $a Dunlevy, Fiona $u European Cystic Fibrosis Society, Karup, Denmark
- 700 1_
- $a Kasmi, Irena $u "Mother Thereza" Hospital Center, Department of Paediatrics, Tirana, Albania
- 700 1_
- $a Harutyunyan, Satenik $u Yerevan University CF Centre, Muratsan Hospital, Yerevan, Armenia
- 700 1_
- $a Pfleger, Andreas $u Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology and Allergology, Medical University of Graz, Graz, Austria
- 700 1_
- $a Keegan, Svetlana $u Belarusian Republic Children's Center of Pulmonology and Cystic Fibrosis, Pulmonary Department, 3rd City Children's Clinical Hospital, Minsk, Belarus
- 700 1_
- $a Daneau, Géraldine $u Sciensano, Epidemiology and public health, Health services research, Brussels, Belgium
- 700 1_
- $a Petrova, Guergana $u Alexandrovska University Hospital, Pediatric Clinic, Sofia, Bulgaria
- 700 1_
- $a Tješić-Drinković, Duška $u University Hospital Centre Zagreb, Cystic Fibrosis Centre - Paediatrics and Adults, Zagreb, Croatia
- 700 1_
- $a Yiallouros, Panayiotis $u Medical School, University of Cyprus, Nicosia, Cyprus
- 700 1_
- $a Bilkova, Alena $u Cystic Fibrosis Registry of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Olesen, Hanne Vebert $u Department of Pediatrics and Adolescent Medicine, Cystic Fibrosis Center, Aarhus University Hospital, Aarhus, Denmark
- 700 1_
- $a Burgel, Pierre-Régis $u Respiratory Medicine and National Cystic Fibrosis Reference Center, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Institut Cochin, INSERM U1016, Paris, France
- 700 1_
- $a Parulava, Tsitsino $u I. Tsitsishvili Children's Clinic, CF Centre, Tblisi, Georgia
- 700 1_
- $a Diamantea, Filia $u Sismanoglio General Hospital of Attica, Adult Cystic Fibrosis Unit, Athens, Greece
- 700 1_
- $a Párniczky, Andrea $u Heim Pál National Pediatric Institute, Budapest, Hungary; Institute for Translational Medicine, University of Pécs, Medical School, Pécs, Hungary
- 700 1_
- $a McKone, Edward F $u St. Vincent's University Hospital & University College Dublin School of Medicine, Dublin, Ireland
- 700 1_
- $a Mei-Zahav, Meir $u Pulmonary Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- 700 1_
- $a Salvatore, Marco $u Undiagnosed Rare Diseases Interdepartmental Unit, National Center Rare Diseases, Istituto Superiore di Sanità, Rome, Italy
- 700 1_
- $a Colombo, Carla $u Cystic Fibrosis Regional Reference Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy
- 700 1_
- $a Aleksejeva, Elina $u Department of Pneumology, Children's Clinical University Hospital, Rīga Stradinš University, Riga, Latvia
- 700 1_
- $a Malakauskas, Kestutis $u Adult Cystic Fibrosis center, Department of Pulmonology, Lithuanian University of Health Sciences, Kaunas, Lithuania
- 700 1_
- $a Schlesser, Marc $u Department of Pulmonology, Hôpital Robert Schuman, Luxembourg, Luxembourg
- 700 1_
- $a Fustik, Stojka $u Centre for Cystic Fibrosis, University Children's Hospital, Skopje, North Macedonia
- 700 1_
- $a Turcu, Oxana $u Ambulatory Cystic Fibrosis and Other Rare Diseases Center, Institute for Maternal and Child Healthcare, State University of Medicine and Pharmacy "Nicolae Testemitanu", Department of Pediatrics, Chisinau, Republic of Moldova
- 700 1_
- $a Zomer-van Ommen, Domenique $u Dutch Cystic Fibrosis Foundation (NCFS), Baarn, The Netherlands
- 700 1_
- $a Wathne, Anita Senstad $u Norwegian Resource Centre for Cystic Fibrosis, Oslo University Hospital, Oslo, Norway
- 700 1_
- $a Woźniacki, Łukasz $u Dziekanow Paediatric Hospital, Cystic Fibrosis Centre, Institute of Mother and Child, Warsaw, Poland
- 700 1_
- $a Pereira, Luísa $u Centre for Cystic Fibrosis, Hospital de Santa Maria, Lisbon, Portugal
- 700 1_
- $a Pop, Liviu $u Victor Babes University of Medicine and Pharmacy Timisoara, National Cystic Fibrosis Centre Timisoara, Romania
- 700 1_
- $a Kashirskaya, Nataliya $u Laboratory of genetic epidemiology, "Research Centre for Medical Genetics", Moscow, Russian Federation
- 700 1_
- $a Rodić, Milan $u National Centre for Cystic Fibrosis, Mother and Child Health Institute of Serbia "Dr Vukan Čupić", Belgrade, Serbia
- 700 1_
- $a Kayserova, Hana $u Cystic Fibrosis Centre, University Hospital of Bratislava, Bratislava, Slovakia
- 700 1_
- $a Krivecs, Uro $u Department of Paediatric Pulmonology, University Children's Hospital, Ljubljana University Medical Centre, Ljubljana, Slovenia
- 700 1_
- $a Mondejar-Lopez, Pedro $u Pediatric Pulmonology and Cystic Fibrosis Unit, Virgen de la Arrixaca Clinic University Hospital, Murcia, Spain
- 700 1_
- $a de Monestrol, Isabelle $u Stockholm CF centre, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Dogru, Deniz $u Cystic Fibrosis Registry of Turkey, Ankara, Turkey
- 700 1_
- $a Makukh, Halyna $u Institute of Hereditary Pathology Ukrainian National Academy of Medical Sciences, Lviv, Ukraine
- 700 1_
- $a Cosgriff, Rebecca $u Cystic Fibrosis Trust, London, UK
- 700 1_
- $a van Koningsbruggen-Rietschel, Silke $u CF-Center, University of Cologne, Faculty of Medicine, Cologne, Germany
- 700 1_
- $a Jung, Andreas $u Paediatric Pulmonology, University Children`s Hospital Zurich, Zurich, Switzerland
- 710 2_
- $a European Cystic Fibrosis COVID project group
- 773 0_
- $w MED00006892 $t Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society $x 1873-5010 $g Roč. 20, č. 4 (2021), s. 566-577
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34016559 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133807 $b ABA008
- 999 __
- $a ok $b bmc $g 1714493 $s 1145969
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 20 $c 4 $d 566-577 $e 20210418 $i 1873-5010 $m Journal of cystic fibrosis $n J Cyst Fibros $x MED00006892
- LZP __
- $a Pubmed-20211013